Merger strengthens European service and expands cardiovascular customization capabilities see more
Merger strengthens European service and expands cardiovascular customization capabilities
(Victoria, Canada and Marseille, France) September 17, 2019 – ViVitro Labs, the industry-leading provider of cardiovascular device test equipment and related consulting services, announces the acquisition of ProtomedLabs SASU, an ISO 17025 accredited medical device testing laboratory based in Marseille France.
The companies will merge operations and form a single company operating under the name of ViVitro Labs Inc. The new organization extends ViVitro’s presence in Europe and doubles the company’s contract testing and customization capabilities. Karim Mouneimne, General Manager of ProtomedLabs, will become President of the combined organization and move to ViVitro headquarters in Victoria, Canada.
(L-R) Karim Mouneimne, General Manager ProtomedLabs and President ViVitro Labs, with Scott Phillips, ViVitro Labs CEO
“This acquisition and merger reflects our commitment to growing ViVitro’s resources, products and services to address evolving cardiovascular testing system needs for leading edge researchers and organizations,” said Scott Phillips, Owner and CEO of the StarFish Group and CEO of ViVitro Labs.
“ProtomedLabs has been the ViVitro sales agent for Europe, Israel, and Africa since 2015. We are excited to bring this successful partnership to the next level,” said Frederic Mouret, President & CEO, Protomed SA and owner of ProtomedLabs.
“Helping companies solve testing challenges by using our equipment and customized testing strategies is part of ViVitro’s unique heritage. We go beyond standard catalog items or services,” said Karim Mouneimne. “Our new larger capacity will allow us to aggressively invest in our product lineup while expanding customized service offerings for clients across the cardiovascular industry.”
About ViVitro Labs
ViVitro Labs Inc., Canada, offers industry-leading cardiovascular test equipment and related laboratory testing and consulting services. Hundreds of organizations in over 39 countries for 30 years have trusted ViVitro expertise, accuracy, and quality for their heart valve, LVAD, TAH, stent, and graft testing. ViVitro Laboratory Services holds ISO/IEC 17025 accreditation based on ISO 5840. ViVitro Labs products are manufactured by StarFish Medical in Victoria, Canada.
ProtomedLabs SASU, Marseille, France, is an ISO 17025 accredited medical device testing laboratory which provides responsive turnkey engineering solutions in device testing for companies developing implantable and interventional cardiovascular devices. ProtomedLabs was 100% owned by Protomed SA, Strasbourg, France.
About Protomed SA
Protomed SA, Strasbourg, France, is an ISO 13485 certified contract service R&D company specialized in medical device design and development. PROTOMED has been driver in the development of several minimally invasive surgery, single use devices, vascular and cardiac implants. Its fab lab includes prototyping machines (3D printers; CNC machines), test benches, control equipment and state of the heart CAD software.
About Starfish Group
StarFish Group is a privately owned company focused on medical device and life sciences markets. The company consists of StarFish Medical, Canada’s largest medical device design, development and contract manufacturing company, and ViVitro Labs.
For more information please contact:
Director of Marketing
ArticleSurgeons in Italy discovering an artificial mitral valve that is almost 50 years old. see more
Source: ViVitro Labs
Celebrating 45 Years of Cardiovascular Pioneers
This week's news of surgeons in Italy discovering an artificial mitral valve that is almost 50 years old and still working illustrates the impact and connection today's pioneers share with their predecessors. I can only imagine how they felt while performing heart surgery on the 60-year-old woman.
The hospital said "A very important piece of the history of world medicine has passed through the hands of heart surgeons of the AOU San Giovanni di Dio and Ruggi d'Aragona of Salerno: a cardiac prosthesis implanted by Christiaan Barnard,"
At ViVitro we salute our pioneering founders and their products as we continue to build upon their legacy serving today's new cardiovascular products, procedures, and technologies.
Please explore our ongoing interviews with cardiovascular pioneers and the latest research articles that use and cite ViVitro equipment and services.
For information on how our services and equipment can help your cardiovascular device research, testing, and development, please contact Douglas Bigrigg or the authorized sales agent in your area.
Starfish Medical has acquired Toronto medical-device designer Kangaroo Group. see more
Victoria medical-device maker Starfish acquires Toronto firm
In a bid to attract more business from the medical-technology hubs of the eastern U.S., Starfish Medical has extended its rays across the country and acquired Toronto medical-device designer Kangaroo Group.
Terms of the sale have not been released, but the result will be a single company with headquarters in Victoria under the Starfish name.
“There are lots of transformations when you’re in our kind of business. We feel we are reinventing ourselves every couple of years and this is just another one,” said Starfish founder Scott Phillips. “The innovation and change is relentless.”
The acquisition, apart from establishing Starfish as a national medical-device developer, will put the company on the radar of medical-technology companies that have clustered in Boston and Minneapolis.
“We weren’t getting very good access to that. We cover the west particularly well, but once in a while we’d lose a job because people thought it might be a hassle to visit us,” said Phillips.
He said Kangaroo has been well represented in eastern Canada, but hasn’t made much headway into the U.S. “That’s our opportunity — to use this location and make much more of an impact.”
Phillips said establishing Starfish across the country also reinforces the brand and sends the message the company can handle big jobs from larger companies.
The company Starfish has acquired has about 25 employees, adding to the 100 at Starfish.
“Kangaroo has a core strength in industrial design and Starfish has core strengths in physics, software, electronic design, optics, ultrasound and other core technologies. I’m excited to see what we can do together,” said Phillips.
For Lahav Gil, founder and chief executive of Kangaroo who will now be vice-president of innovation for Starfish, the merger seemed to be destined.
“It’s magical how that happened and how we’re at that point where it seems frictionless,” he said. “Existing Kangaroo clients will experience much more robust service and offerings. On the product development side, they will be able to tap into a plethora of additional expertise. In manufacturing they’ll find an expanded supply chain and regulatory personnel and expertise.”
Phillips said Kangaroo had the right culture and outlook.
“We looked at several companies, but the guys in Toronto were a good fit,” Phillips said, noting they shared the same drive to get to the bottom of things and to constantly be innovative.
“We felt most mergers fail due to culture and we wanted to find one that had a foundation we could work with from all the way across the country.”
That was key as none of Starfish’s senior managers wanted to leave the Island to oversee the Toronto operation.
Phillips said there will be a learning curve the company works through as teams in Victoria will be working with counterparts in Toronto.
“That’s something we have to figure out how to do effectively,” he said.
The sale comes after more than two years of intense growth at Starfish, which has expanded within its own Victoria offices and maintained a healthy hiring pace.
Phillips said Starfish has seen 50 per cent growth in each of the last two years.
“It’s kind of remarkable how the company has changed,” said Phillips. “There has been so much demand the last few years, we’re at a break-neck pace.
“We did want to take a breath and re-tool, and yet here we have just bought a company and hired 10 new people.”
Phillips said he wants to take a cautious approach to future expansion, and will focus on building business in the east before looking at expansion on the West Coast of the U.S.
The recent growth spurt appears to be down to the nature of the business.
The company is 17 years old and has enough satisfied clients to develop and enhance its reputation in the medical device field. “Work in this field is a matter of reputation and referral,” said Phillips noting most sizable projects can take five years or more to complete. “So it takes a while to build up a reputation.”
Vivitro and StarFish Medical salute their employees’ community efforts during the season of giving! see more
Vivitro Employees Embrace the Community Spirit of the Season
VICTORIA, British Columbia, November 30, 2016 – ViVitro Labs, a global leader in cardiovascular device testing, and StarFish Medical, Canada’s largest medical device design, development, and contract manufacturing company, salute their employees’ community efforts during the season of giving. This November and December employees are raising awareness and funds for BC Children’s Hospital and Mustard Seed Food Bank. ViVitro and StarFish match employee donations and cover all sponsorship fees to encourage participation.
Victoria Festival of Trees
Each year ViVitro Labs and StarFish Medical sponsor a tree in the Festival of Trees fundraising campaign for BC Children’s Hospital. The festival knits together the incredibly generous community of Victoria in what has become, over the last two decades, a cherished holiday tradition and the unofficial kick-off to the holiday season in the city.
This year the ViVitro Labs/StarFish Medical tree’s theme is: “We look deeper to help make holidays healthy for everyone!” The tree features an LED X-ray branch outline and ornaments that include hand crafted “x-ray” images for traditional holiday gifts. A custom booklet shares the significance of both companies’ work and the tree’s design. Judges awarded the concept and execution top marks in all categories at the November 16 Opening Gala.
The tree is on display through January 3, 2017 at the Empress Hotel. 85 beautiful trees were decorated, and over 550 guests attended the Kick-Off Celebration and $106,400 was raised through tree registrations.
Fundraising continues online via the Festival of Trees Online Voting System. Fundraising tool for online vote collection. Visitors can make a donation and vote for the ViVitro Labs/StarFish Medical tree on the Victoria Festival of Trees StarFish Medical Webpage.
2016 VIATEC Food Bank Challenge for Mustard Seed
Hayley Young manages ViVitro Labs and StarFish Medical participation in the 2016 VIATEC Food Bank Challenge for Mustard Seed. Organized by VIATEC (Victoria Innovation, Advanced Technology and Entrepreneurship Council), this annual food bank drive challenges companies in Victoria to compete in an effort to raise as much food and donations as possible for the Mustard Seed Food Bank.
ViVitro Labs and StarFish Medical fundraising events include a Chilli/Curry cook-off, 50/50 raffle, and Social Committee lunch. The 2016 Chilli/Curry cook off fundraiser was held November 17, and raised $590.00. 1st prize went to Debbie Gould, 2nd prize went to Savannah Hari, and 3rd prize went to Michael May. The 50/50 stubs raised $535.
The Mustard Seed provides support to 7000 people each month. Since its inception in 2002, $1,981,296.84 worth of food and cash has been donated to the Mustard Seed through companies participating in the VIATEC Food Bank Challenge. The 2016 challenge runs from November 7th to December 2nd. Donations are accepted online.
About ViVitro Labs
ViVitro Labs Inc. offers industry-leading cardiovascular test equipment and related laboratory testing and consulting services. Hundreds of organizations in over 40 countries for over 30 years have trusted ViVitro expertise, accuracy, and quality for their heart valve, LVAD, TAH, stent, and graft testing. ViVitro Laboratory Services holds ISO/IEC 17025 accreditation based on ISO 5840. ViVitro products are manufactured by StarFish Medical. ViVitro’s A2LA Scope of Accreditation includes the physical and mechanical testing of heart valve substitutes. www.vivitrolabs.com
For more information please contact: